Archives

by in
Entry Author Date Location
GlaxoSmithKline Shuts Down Sirtris, Five Years After $720M Buyout 03/12/13 Boston
Join Us for ‘Boston Biotech Seizes the Momentum’ on April 4 02/07/13 Boston
OvaScience, Founded by Sirtris Vets, Plans IPO 08/30/12 Boston
Adimab, ImmunoGen, OvaScience, & More Boston Life Sciences News 04/06/12 Boston
Verastem Bucks the Trend, Raises $55M in IPO 01/26/12 Boston
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011 11/07/11 National
Langer Nabs Cash From Rock Stars, Verastem Seeks $50M IPO, Alnylam Snags RNAi Collab, & More Boston-Area Life Sciences News 11/04/11 Boston
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO 11/03/11 Boston
Tolerx Shutters, Courtagen Gets $8M, OvaScience Emerges, & More Boston-Area Life Sciences News 10/14/11 Boston
OvaScience Uses Stem Cells to Revive Fertility 10/12/11 Boston
Verastem, Rooted at MIT, Raises $32 Million and Adds ATV and Astellas to Slate of Investors 07/14/11 Boston
Termeer Joins Verastem Board 06/13/11 Boston
SR One Opens Bay Area Shop 04/26/11 San Francisco
The New Tech Bubble, Biotech Vs. Big Pharma, and More Thoughts from Boston BD Conference 04/14/11 Boston
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News 01/07/11 Boston
Rich Aldrich, Biotech Powerbroker, Breaks Silence on New $87M Longwood Founders Fund 01/06/11 Boston
SCVNGR Scares Up $15M, Genocea Gets $35M, Zeo Zeros in on $12.3M, & More Boston-Area Deals News 01/05/11 Boston
Longwood Raises $85M First Fund 01/03/11 Boston
Verastem, Founded by MIT Big Names, Raises $16M to Fight Cancer Stem Cells 11/16/10 Boston
Dicerna Gets Glaxo’s SR One to Join Investor Syndicate 10/21/10 Boston
Biogen Strikes Deal with Knopp for ALS Drugs, Selecta Gets New CEO, Avantra Scores $7M, & More Boston-Area Life Sciences News 08/20/10 Boston
Report: Former Sirtris Execs Ordered to Stop Selling Resveratrol Dietary Supplement Online 08/13/10 Boston
Former Sirtris Execs’ Nonprofit Starts Selling Resveratrol with Potential Anti-Aging Effects Online 08/12/10 Boston
Drug Giant Eli Lilly Buys Alnara Pharma To Get Cystic Fibrosis Drug 07/02/10 Boston
Flagship Plans $300M New Fund, Boston TechStars Pitch to Area Investors, AutoVirt Raises $1.5M, & More Boston-Area Deals News 06/09/10 Boston
Follica Grabs $7.5M, Glaxo’s SR One Leads $22M Round For Constellation, MoMelan Seeks to Improve Skin Grafts, & More Boston-Area Life Sciences News 06/04/10 Boston
Glaxo’s SR One Injects Pharma Bucks into $22M Round for Constellation Pharma 06/02/10 Boston
Glaxo Stops Study of Sirtris “Red Wine” Drug in Cancer Patients 05/05/10 Boston
Genzyme Expects to Pay $175M to FDA, Westphal Leaves Sirtris to Run GSK Venture Arm, Gelesis Obesity Treatment Passes First Human Trial, & More Boston-Area Life Sciences News 04/23/10 Boston
Sirtris Vet Michelle Dipp Takes Over Key Role at Glaxo as Westphal Returns to VC 04/22/10 Boston
Page 1 of 3 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  2. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.